Relief Therapeutics (Switzerland) Analysis
| RLF Stock | CHF 2.24 0.02 0.90% |
Relief Therapeutics Holding is overvalued with Real Value of 2.06 and Hype Value of 2.24. The main objective of Relief Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Relief Therapeutics Holding is worth, separate from its market price. There are two main types of Relief Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Relief Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Relief Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Relief Therapeutics stock is traded in Switzerland on SIX Swiss Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Switzerland. Relief Therapeutics is usually not traded on Good Friday, Berchtoldstag, Easter Monday, International Workers ' Day, Ascension Day ( 2025 ), Whitmonday ( 2025 ), National Day, Christmas Eve ( 2025 ), Christmas Day, St . Stephen 's Day, New Year 's Eve ( 2025 ), New Year 's Day. Relief Stock trading window is adjusted to Europe/Zurich timezone.
Relief |
Relief Stock Analysis Notes
About 22.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.76. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Relief Therapeutics has Price/Earnings (P/E) ratio of 277.0. The entity recorded a loss per share of 0.01. The firm had not issued any dividends in recent years. Relief Therapeutics had 400:1 split on the 3rd of May 2023. Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company was founded in 2013 and is based in Geneva, Switzerland. RELIEF THERAPEUTICS operates under Pharmaceuticals And Biosciences classification in Switzerland and is traded on Switzerland Exchange. It employs 10 people. To find out more about Relief Therapeutics Holding contact the company at 41 44 723 59 59 or learn more at https://www.relieftherapeutics.com.Relief Therapeutics Investment Alerts
| Relief Therapeutics had very high historical volatility over the last 90 days | |
| Relief Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 3.32 M. Net Loss for the year was (34.7 M) with profit before overhead, payroll, taxes, and interest of 2.57 M. | |
| Relief Therapeutics Holding has accumulated about 29.87 M in cash with (35.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
Relief Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 114.81 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Relief Therapeutics's market, we take the total number of its shares issued and multiply it by Relief Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 22nd of July, Relief Therapeutics holds the Semi Deviation of 4.05, risk adjusted performance of 0.0197, and Coefficient Of Variation of 8448.0. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Relief Therapeutics, as well as the relationship between them. Please check Relief Therapeutics value at risk, and the relationship between the jensen alpha and semi variance to decide if Relief Therapeutics is priced some-what accurately, providing market reflects its current price of 2.24 per share.Relief Therapeutics Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Simple Moving Average indicator is calculated by adding the closing price of Relief Therapeutics for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Relief Therapeutics short-term fluctuations and highlight longer-term trends or cycles.
Relief Therapeutics Outstanding Bonds
Relief Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Relief Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Relief bonds can be classified according to their maturity, which is the date when Relief Therapeutics Holding has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Relief Therapeutics Predictive Daily Indicators
Relief Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Relief Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 342.29 | |||
| Daily Balance Of Power | 0.25 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 2.25 | |||
| Day Typical Price | 2.25 | |||
| Period Momentum Indicator | 0.02 |
Relief Therapeutics Forecast Models
Relief Therapeutics' time-series forecasting models are one of many Relief Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Relief Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Relief Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Relief Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Relief shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Relief Therapeutics. By using and applying Relief Stock analysis, traders can create a robust methodology for identifying Relief entry and exit points for their positions.
Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company was founded in 2013 and is based in Geneva, Switzerland. RELIEF THERAPEUTICS operates under Pharmaceuticals And Biosciences classification in Switzerland and is traded on Switzerland Exchange. It employs 10 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Relief Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Additional Tools for Relief Stock Analysis
When running Relief Therapeutics' price analysis, check to measure Relief Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relief Therapeutics is operating at the current time. Most of Relief Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relief Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relief Therapeutics' price. Additionally, you may evaluate how the addition of Relief Therapeutics to your portfolios can decrease your overall portfolio volatility.